These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8464648)

  • 1. Cefprozil.
    Stutman HR
    Pediatr Ann; 1993 Mar; 22(3):167-8, 171-6. PubMed ID: 8464648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR; Benfield P
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefprozil, a new cephalosporin: its use in various clinical trials.
    Gainer RB
    South Med J; 1995 Mar; 88(3):338-46. PubMed ID: 7886533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin.
    Guay DR
    Clin Ther; 2002 Apr; 24(4):473-89. PubMed ID: 12017394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of upper and lower respiratory tract infections: clinical trials with cefprozil.
    Aronovitz G
    Pediatr Infect Dis J; 1998 Aug; 17(8 Suppl):S83-8. PubMed ID: 9727656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefprozil: a review.
    Bhargava S; Lodha R; Kabra SK
    Indian J Pediatr; 2003 May; 70(5):395-400. PubMed ID: 12841400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of a new oral cephem, cefprozil in children].
    Meguro H; Tajima T; Shiraishi H; Abe T
    Jpn J Antibiot; 1992 Nov; 45(11):1505-13. PubMed ID: 1494233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
    Barriere SL
    Ann Pharmacother; 1993 Sep; 27(9):1082-9. PubMed ID: 8219444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory and clinical studies on cefprozil granules in pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1992 Nov; 45(11):1526-36. PubMed ID: 1494235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral cephalosporins: newer agents and their place in therapy.
    Thompson EM; Shaughnessy AF
    Am Fam Physician; 1994 Aug; 50(2):401-5. PubMed ID: 8042575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic, bacteriological and clinical studies on cefprozil in pediatric patients].
    Arai S; Sono R; Ito M; Sakurai M; Ihara T; Kamiya H; Shimizu S; Nishi H; Inoue M; Kojima M
    Jpn J Antibiot; 1992 Nov; 45(11):1571-81. PubMed ID: 1494238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.
    Christenson JC; Gooch WM; Herrod JN; Swenson E
    J Antimicrob Chemother; 1991 Oct; 28(4):581-6. PubMed ID: 1761453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
    Schatz BS; Karavokiros KT; Taeubel MA; Itokazu GS
    Ann Pharmacother; 1996 Mar; 30(3):258-68. PubMed ID: 8833562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory and clinical studies of cefprozil in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Takagi M
    Jpn J Antibiot; 1992 Nov; 45(11):1582-91. PubMed ID: 1494239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability assessment of cefprozil in children with acute otitis media.
    Gupta N; Bagga V; Parmar BJ; Kar K; Mukherjee A; Mehta S; Moharana AK
    Indian J Pediatr; 2004 Apr; 71(4):319-24. PubMed ID: 15107512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group.
    Iravani A; Doyle CA; Durham SJ; Wilber RB
    Clin Ther; 1992; 14(2):314-26. PubMed ID: 1611652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory and clinical studies on cefprozil in the field of pediatrics].
    Hayakawa F; Kuno K; Ogawa A; Nakao Y; Ando Y; Ando H
    Jpn J Antibiot; 1992 Nov; 45(11):1558-70. PubMed ID: 1494237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections.
    Gerber JS; Ross RK; Bryan M; Localio AR; Szymczak JE; Wasserman R; Barkman D; Odeniyi F; Conaboy K; Bell L; Zaoutis TE; Fiks AG
    JAMA; 2017 Dec; 318(23):2325-2336. PubMed ID: 29260224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
    Kafetzis DA
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):857-65. PubMed ID: 7889960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.